Search research articles
Contact Us
Filters
Showing results (111-120 of 261) with videos related to
Page
of 27
Sort By:
Clinical and Translational Medicine
|
February 9, 2025
Spatial‒temporal heterogeneities of liver cancer and the discovery of the invasive zone
Jiayan Yan, Zhifeng Jiang, Shiyu Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2010
Exploratory analysis of early toxicity of sunitinib in advanced hepatocellular carcinoma patients: kinetics and potential biomarker value
Andrew X Zhu, Dan G Duda, Marek Ancukiewicz, et al.
Scientific Reports
|
August 24, 2022
Immune modulation by molecularly targeted photothermal ablation in a mouse model of advanced hepatocellular carcinoma and cirrhosis
Nina M Muñoz, Crystal Dupuis, Malea Williams, et al.
Cancer Research
|
November 8, 2024
Fluorescence Lifetime Imaging Enables In Vivo Quantification of PD-L1 Expression and Intertumoral Heterogeneity
Rahul Pal, Murali Krishnamoorthy, Aya Matsui, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 19, 2006
Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage
Janka Kisucka, Catherine E Butterfield, Dan G Duda, et al.
Research Square
|
November 14, 2023
<i>In vivo</i> quantification of programmed death-ligand-1 expression heterogeneity in tumors using fluorescence lifetime imaging
Rahul Pal, Murali K, Aya Matsui, et al.
Nature Reviews. Clinical Oncology
|
April 1, 2009
VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer
Elizabeth R Gerstner, Dan G Duda, Emmanuelle di Tomaso, et al.
Plos One
|
February 21, 2012
Effects of sorafenib on intra-tumoral interstitial fluid pressure and circulating biomarkers in patients with refractory sarcomas (NCI protocol 6948)
Chandrajit P Raut, Yves Boucher, Dan G Duda, et al.
JCO Clinical Cancer Informatics
|
February 22, 2022
Predictive Modeling of Survival and Toxicity in Patients With Hepatocellular Carcinoma After Radiotherapy
Ibrahim Chamseddine, Yejin Kim, Brian De, et al.
Clinical and Translational Radiation Oncology
|
July 26, 2019
Inter-patient variations of radiation-induced normal-tissue changes in Gd-EOB-DTPA-enhanced hepatic MRI scans during fractionated proton therapy
Christian Richter, Ovidiu C Andronesi, Ronald J H Borra, et al.
Page
of 27
Search research articles
Search
Showing results (111-120 of 261) with videos related to
Sort By:
Page
of 27
Clinical and Translational Medicine
|
February 9, 2025
Spatial‒temporal heterogeneities of liver cancer and the discovery of the invasive zone
Jiayan Yan, Zhifeng Jiang, Shiyu Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2010
Exploratory analysis of early toxicity of sunitinib in advanced hepatocellular carcinoma patients: kinetics and potential biomarker value
Andrew X Zhu, Dan G Duda, Marek Ancukiewicz, et al.
Scientific Reports
|
August 24, 2022
Immune modulation by molecularly targeted photothermal ablation in a mouse model of advanced hepatocellular carcinoma and cirrhosis
Nina M Muñoz, Crystal Dupuis, Malea Williams, et al.
Cancer Research
|
November 8, 2024
Fluorescence Lifetime Imaging Enables In Vivo Quantification of PD-L1 Expression and Intertumoral Heterogeneity
Rahul Pal, Murali Krishnamoorthy, Aya Matsui, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 19, 2006
Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage
Janka Kisucka, Catherine E Butterfield, Dan G Duda, et al.
Research Square
|
November 14, 2023
<i>In vivo</i> quantification of programmed death-ligand-1 expression heterogeneity in tumors using fluorescence lifetime imaging
Rahul Pal, Murali K, Aya Matsui, et al.
Nature Reviews. Clinical Oncology
|
April 1, 2009
VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer
Elizabeth R Gerstner, Dan G Duda, Emmanuelle di Tomaso, et al.
Plos One
|
February 21, 2012
Effects of sorafenib on intra-tumoral interstitial fluid pressure and circulating biomarkers in patients with refractory sarcomas (NCI protocol 6948)
Chandrajit P Raut, Yves Boucher, Dan G Duda, et al.
JCO Clinical Cancer Informatics
|
February 22, 2022
Predictive Modeling of Survival and Toxicity in Patients With Hepatocellular Carcinoma After Radiotherapy
Ibrahim Chamseddine, Yejin Kim, Brian De, et al.
Clinical and Translational Radiation Oncology
|
July 26, 2019
Inter-patient variations of radiation-induced normal-tissue changes in Gd-EOB-DTPA-enhanced hepatic MRI scans during fractionated proton therapy
Christian Richter, Ovidiu C Andronesi, Ronald J H Borra, et al.
Page
of 27